Year |
Citation |
Score |
2016 |
Xu W, Weissmiller AM, White JA, Fang F, Wang X, Wu Y, Pearn ML, Zhao X, Sawa M, Chen S, Gunawardena S, Ding J, Mobley WC, Wu C. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. The Journal of Clinical Investigation. PMID 27064279 DOI: 10.1172/Jci82409 |
0.581 |
|
2016 |
Le MH, Weissmiller AM, Monte L, Lin PH, Hexom TC, Natera O, Wu C, Rissman RA. Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport. Plos One. 11: e0147250. PMID 26790099 DOI: 10.1371/Journal.Pone.0147250 |
0.44 |
|
2015 |
Selfridge A, Hyun N, Chiang CC, Reyna SM, Weissmiller AM, Shi LZ, Preece D, Mobley WC, Berns MW. Rat embryonic hippocampus and induced pluripotent stem cell derived cultured neurons recover from laser-induced subaxotomy. Neurophotonics. 2: 015006. PMID 26157985 DOI: 10.1117/1.Nph.2.1.015006 |
0.535 |
|
2015 |
Nosheny RL, Belichenko PV, Busse BL, Weissmiller AM, Dang V, Das D, Fahimi A, Salehi A, Smith SJ, Mobley WC. Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiology of Disease. 77: 173-90. PMID 25753471 DOI: 10.1016/J.Nbd.2015.02.022 |
0.493 |
|
2015 |
Weissmiller AM, Natera-Naranjo O, Reyna SM, Pearn ML, Zhao X, Nguyen P, Cheng S, Goldstein LS, Tanzi RE, Wagner SL, Mobley WC, Wu C. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. Plos One. 10: e0118379. PMID 25710492 DOI: 10.1371/Journal.Pone.0118379 |
0.599 |
|
2014 |
Zhao X, Zhou Y, Weissmiller AM, Pearn ML, Mobley WC, Wu C. Real-time imaging of axonal transport of quantum dot-labeled BDNF in primary neurons. Journal of Visualized Experiments : Jove. 51899. PMID 25286194 DOI: 10.3791/51899 |
0.565 |
|
2012 |
Rodrigues EM, Weissmiller AM, Goldstein LS. Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects. Human Molecular Genetics. 21: 4587-601. PMID 22843498 DOI: 10.1093/Hmg/Dds297 |
0.513 |
|
Low-probability matches (unlikely to be authored by this person) |
2012 |
Weissmiller AM, Wu C. Current advances in using neurotrophic factors to treat neurodegenerative disorders. Translational Neurodegeneration. 1: 14. PMID 23210531 DOI: 10.1186/2047-9158-1-14 |
0.298 |
|
2015 |
Thomas LR, Foshage AM, Weissmiller AM, Popay TM, Grieb BC, Qualls SJ, Ng V, Carboneau B, Lorey S, Eischen CM, Tansey WP. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif. Oncogene. PMID 26522729 DOI: 10.1038/Onc.2015.416 |
0.121 |
|
2021 |
Popay TM, Wang J, Adams CM, Howard GC, Codreanu SG, Sherrod SD, McLean JA, Thomas LR, Lorey SL, Machida YJ, Weissmiller AM, Eischen CM, Liu Q, Tansey WP. MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1. Elife. 10. PMID 33416496 DOI: 10.7554/eLife.60191 |
0.12 |
|
2022 |
Florian AC, Woodley CM, Wang J, Grieb BC, Slota MJ, Guerrazzi K, Hsu CY, Matlock BK, Flaherty DK, Lorey SL, Fesik SW, Howard GC, Liu Q, Weissmiller AM, Tansey WP. Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. Nar Cancer. 4: zcac007. PMID 35252869 DOI: 10.1093/narcan/zcac007 |
0.118 |
|
2021 |
Guarnaccia AD, Rose KL, Wang J, Zhao B, Popay TM, Wang CE, Guerrazzi K, Hill S, Woodley CM, Hansen TJ, Lorey SL, Shaw JG, Payne WG, Weissmiller AM, Olejniczak ET, et al. Impact of WIN site inhibitor on the WDR5 interactome. Cell Reports. 34: 108636. PMID 33472061 DOI: 10.1016/j.celrep.2020.108636 |
0.104 |
|
2019 |
Thomas LR, Adams CM, Wang J, Weissmiller AM, Creighton J, Lorey SL, Liu Q, Fesik SW, Eischen CM, Tansey WP. Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance. Proceedings of the National Academy of Sciences of the United States of America. PMID 31767764 DOI: 10.1073/Pnas.1910391116 |
0.104 |
|
2022 |
Siladi AJ, Wang J, Florian AC, Thomas LR, Creighton JH, Matlock BK, Flaherty DK, Lorey SL, Howard GC, Fesik SW, Weissmiller AM, Liu Q, Tansey WP. WIN site inhibition disrupts a subset of WDR5 function. Scientific Reports. 12: 1848. PMID 35115608 DOI: 10.1038/s41598-022-05947-9 |
0.104 |
|
2020 |
Bryan AF, Wang J, Howard GC, Guarnaccia AD, Woodley CM, Aho ER, Rellinger EJ, Matlock BK, Flaherty DK, Lorey SL, Chung DH, Fesik SW, Liu Q, Weissmiller AM, Tansey WP. WDR5 is a conserved regulator of protein synthesis gene expression. Nucleic Acids Research. PMID 31996893 DOI: 10.1093/Nar/Gkaa051 |
0.098 |
|
2015 |
Thomas LR, Foshage AM, Weissmiller AM, Tansey WP. The MYC-WDR5 Nexus and Cancer. Cancer Research. 75: 4012-5. PMID 26383167 DOI: 10.1158/0008-5472.Can-15-1216 |
0.095 |
|
2019 |
Aho ER, Weissmiller AM, Fesik SW, Tansey WP. Targeting WDR5: A WINning Anti-Cancer Strategy? Epigenetics Insights. 12: 2516865719865282. PMID 31360909 DOI: 10.1177/2516865719865282 |
0.092 |
|
2022 |
Moe KC, Maxwell JN, Wang J, Jones CA, Csaki GT, Florian AC, Romer AS, Bryant DL, Farone AL, Liu Q, Tansey WP, Weissmiller AM. The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells. Oncogenesis. 11: 30. PMID 35650187 DOI: 10.1038/s41389-022-00406-6 |
0.09 |
|
2019 |
Aho ER, Wang J, Gogliotti RD, Howard GC, Phan J, Acharya P, Macdonald JD, Cheng K, Lorey SL, Lu B, Wenzel S, Foshage AM, Alvarado J, Wang F, Shaw JG, ... ... Weissmiller AM, et al. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity. Cell Reports. 26: 2916-2928.e13. PMID 30865883 DOI: 10.1016/J.Celrep.2019.02.047 |
0.086 |
|
2019 |
Weissmiller AM, Wang J, Lorey SL, Howard GC, Martinez E, Liu Q, Tansey WP. Inhibition of MYC by the SMARCB1 tumor suppressor. Nature Communications. 10: 2014. PMID 31043611 DOI: 10.1038/S41467-019-10022-5 |
0.085 |
|
2022 |
Jones CA, Tansey WP, Weissmiller AM. Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation. Epigenetics Insights. 15: 25168657221115656. PMID 35911061 DOI: 10.1177/25168657221115656 |
0.079 |
|
2023 |
Bumpous LA, Moe KC, Wang J, Carver LA, Williams AG, Romer AS, Scobee JD, Maxwell JN, Jones CA, Chung DH, Tansey WP, Liu Q, Weissmiller AM. WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines. Oncogenesis. 12: 32. PMID 37336886 DOI: 10.1038/s41389-023-00477-z |
0.073 |
|
2024 |
Weissmiller AM, Fesik SW, Tansey WP. WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think. Journal of Clinical Medicine. 13. PMID 38202281 DOI: 10.3390/jcm13010274 |
0.073 |
|
2023 |
Thammathong J, Chisam KB, Tessmer GE, Womack CB, Sidrak MM, Weissmiller AM, Banerjee S. Fused Imidazopyrazine-Based Tubulin Polymerization Inhibitors Inhibit Neuroblastoma Cell Function. Acs Medicinal Chemistry Letters. 14: 1284-1294. PMID 37736192 DOI: 10.1021/acsmedchemlett.3c00298 |
0.067 |
|
2021 |
Woodley CM, Romer AS, Wang J, Guarnaccia AD, Elion DL, Maxwell JN, Guerrazzi K, McCann TS, Popay TM, Matlock BK, Flaherty DK, Lorey SL, Liu Q, Tansey WP, Weissmiller AM. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler. Oncogene. PMID 33931740 DOI: 10.1038/s41388-021-01804-7 |
0.066 |
|
2021 |
Guarnaccia AD, Weissmiller AM, Tansey WP. Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells. Star Protocols. 2: 101000. PMID 34917979 DOI: 10.1016/j.xpro.2021.101000 |
0.062 |
|
Hide low-probability matches. |